NEW YORK, Dec. 7, 2012 /PRNewswire/ -- 5WPR, one of the 25 largest independent Public Relations firms in the U.S., today announced the addition of Absorption Pharmaceuticals to its diverse roster of consumer product clients. Absorption Pharmaceuticals is the manufacturer of Promescent, the only FDA-approved topical use treatment for premature ejaculation (PE). For Absorption Pharmaceuticals, 5W Public Relations will execute a multi-tiered media relations campaign.
"We are excited to be working with this innovative company," said Ronn Torossian, Founder of 5W Public Relations. "We look forward to helping this brand capture additional market share and elevating its visibility within leading media."
"As Absorption Pharmaceuticals continues to expand and offer an exceptional product to consumers, we are excited to let consumers know about our life-changing product," said Jeff Abraham, CEO of Absorption Pharmaceuticals.
ABOUT 5W PUBLIC RELATIONS:
5W Public Relations (5W) is a full-service agency known for cutting edge programs that engage people with businesses, issues and ideas. With more than 90 professionals serving clients in B2C (Beauty & Fashion, Consumer Brands, Entertainment, Food & Beverage, Health & Wellness, Travel & Hospitality, Technology, Nonprofit), B2B (Corporate Communications, Reputation Management, CSR, Sustainability Communications), Public Affairs, Crisis Communications and digital strategy, 5W brings leading businesses a resourceful, bold and results driven approach to communications. Learn more at www.5wpr.com.
SOURCE 5W Public Relations